According to this month's Veterinary Practice magazine, Vetstream Ltd., the erstwhile publisher of Veterinary Review, has been granted a Company Voluntary Arrangement under the Insolvency Act 1986.
VP reports that the CVA is an alternative to liquidation which in this case will allow Vetstream to make a partial repayment to it's creditors (who are collectively owed £1.15 million) of 40.08p in the pound over three years.
As I reported earlier, Vetstream Ltd now plans to focus on electronic media, including its CD-Rom products (Canis, Felis, Equis and Lapis) and www.myvetstream.com.
With the latter, they face some stiff competition, not least from this site which uses state-of-the-art software to provide the latest networking and information sharing features for vets, but also vetsonline.com, a more recent entrant to the marketplace from the publishers of Vet Times.
Virbac Animal Health has launched Allerderm, a topical spot on product designed to rebuild the epidermal barrier in dogs and cats with skin problems.
According to the company, Allerderm Spot-On contains a mimic of the normal lamellar lipids found in the stratum corneum: essential fatty acids, ceramides and cholesterol.
Virbac Product Manager Chris Geddes MRCVS said: The "outside-in" theory of inflammatory skin disease is now widely accepted - that is, the belief that a faulty epidermal barrier is the primary problem, allowing penetration of allergens which then triggers inflammation in the underlying skin.
"A healthy epidermal barrier is designed to keep in water and moisture, and keep out allergens and pathogens. The 'barrier repair' approach has been developed in human medicine and is now proving true in companion animal care.
"It is currently possible to help restore this barrier with oral essential fatty acid supplements like Complederm and with Allermyl shampoo, but this is an exciting new addition to the armoury."
Mr Geddes added: "In a study of allergic dogs1, researchers found that Allerderm spot on caused the level of lipids on the stratum corneum to return to almost the level of normal dogs."
Allerderm Spot-On is applied along the back of the dog or cat initially at weekly intervals, eventually reducing to monthly applications. It is available in packs of 6 pipettes in 2ml (suitable for cats and dogs less than 10kg) and 4ml (suitable for dogs over 10kg).
For further information on Allerderm Spot-On, contact your local Virbac territory manager or call Virbac on 01359 243243.
Reference1. Effects of a Topically Applied Preparation of Epidermal Lipids on the Stratum Corneum Barrier of Atopic Dogs, A. Piekutowska, D. Pin, C.A. Réme, H. Gatto and M. Haftek, Journal of Comparative Pathology 2008, Vol. 138, 197-203
Norbrook Laboratories Ltd has launched Cleanor, an ear cleaner for cats and dogs.
Norbrook says Cleanor Ear Cleaner has been developed for regular, routine cleaning to help remove excessive ear wax from the ear canal as well as providing a moisturising effect to the ear canal's delicate epithelium.
Michelle Jones, Norbrook Brand Manager (Small Animals) said: "Ear disease represents one of the most common skin problems seen in veterinary practice. Checking the cat or dog's ears should be part of the normal health routine for pet owners. Cleanor Ear Cleaner has been designed to make the ear cleaning process simple and stress free for both the animal and owner. It comes with a long, soft and flexible nozzle to allow easy access to the ear canal and is gentle enough to treat even the most sensitive ears."
Cleanor Ear Cleaner is available in two sizes: 50ml and 120ml. It is supported by educational brochures to assist veterinary practices in discussing good ear cleaning practice with their clients. The brochures are available through Norbrook's local sales representatives.
Cleanor Ear Cleanor is available in the UK, Northern Ireland and the Republic of Ireland.
Candidates will have the option of receiving a PGDip Veterinary Physiotherapy after two years, and will be able to practice as veterinary physiotherapists with either qualification.
The course will be delivered at the University’s Sutton Bonington campus at weekends, so that it can fit around people's existing work commitments.
Leading the course at Nottingham will be Dr Richard Payne, Assistant Professor of Veterinary Anatomy. He said: "This is an exciting expansion of our postgraduate provision and will allow us to build on our reputation for delivering first class teaching in our excellent facilities.
"The course will be run on a weekend basis over two academic years, which will allow students to continue to work in their current employment. It is very much hands-on and is designed for musculoskeletal practitioners, veterinary nurses and veterinary surgeons, but also for those who want to expand or change their career opportunities."
The course was developed by Canine and Equine Physiotherapy Training (CEPT) and has been delivered by them since 2008, but is being transferred to Nottingham due to an increasing number of applicants.
The University says much of the practical teaching will be delivered by qualified veterinary physiotherapists, both on campus and at their own practices.
Students will be qualified as veterinary physiotherapists after two years, while the third year for the MSc will revolve around research work for a dissertation based on a topic relevant to veterinary physiotherapy.
Modules will cover a range of topics including the foundations of clinical practice, anatomy and physiology, the foundations of clinical practice, applied clinical skills and clinical reasoning and reporting. Students can expect to come away with a range of practical skills such as physiotherapy, electrotherapy and exercise programming.
The course will be open to applicants with a degree (BSc or above) in a science or animal-related subject and with evidence of at least eight weeks of animal handling experience.
More information about the course, and how to apply, can be found at https://www.nottingham.ac.uk/pgstudy/courses/veterinary-medicine-and-science/veterinary-physiotherapy-msc-pgdip.aspx
Photo courtesy University of Nottingham
The University of Liverpool's School of Veterinary Science has announced the introduction of a new curriculum designed to enhance undergraduate veterinary teaching and learning.
The University says that the curriculum, which was developed in consultation with staff, current and past students, and other key stakeholders, will provide world-leading clinical training, underpinned with the latest scientific knowledge.
The review also explored new ways of teaching in order to reduce the number of lectures in favour of more dynamic forms of training, such as 'scenario' sessions where students work in groups to tackle clinical problems.
Dr Alex German, programme director for the new curriculum, said: "Instead of a modular format, where subjects are taught in self-contained units, we now integrate subjects throughout the degree programme so that students can seamlessly connect what they have learnt to what they are practising.
"Pre-clinical subjects are taught early on, but then revisited during the later stages of the course to ensure that clinical knowledge is based on sound physiological and pathophysiological principles."
Fundamental research skills, such as basic statistics and scientific writing, are taught in the early years, and then reinforced when students undertake a full honours-degree-equivalent research project in their third year.
Evidence-based veterinary medicine principles also underpin all clinical subjects, enabling undergraduates to review clinical evidence critically, and appraise new data as it emerges.
The most significant changes, however, focus on the teaching of clinical skills, which is now taught throughout the five-year programme. To support this, the School has appointed a number of new lecturers specifically to teach clinical skills, and opened new purpose-built teaching laboratories.
Teaching includes the use of models such as a cattle obstetric simulator, a life-size model of a horse with foam pads for practising injections, and a 'Lambinator' for lambing practise. Many of the models have been designed and built by the new lecturers.
A 'cow laboratory' has also been developed to provide an area for self-directed teaching where students can practise skills such as, haltering and casting a cow, learning how to cast a calf's leg, and perform rectal examination with the use of 'Betsy', the in-house reproductive tract simulator (pictured right).
Alison Reid, clinical skills lecturer, said: "When I qualified ten years ago, I could not confidently perform some of the skills we are now teaching our first year students and I remember how unnerving that was when I first entered practice.
"If we can take away the difficulty associated with performing unfamiliar manual skills under pressure, we will be improving the lives of our graduates, their colleagues and their patients."
Speaking at the MSD Animal Health sponsored National Mastitis Panel, David said that more widespread understanding of the issues is urgently required particularly amongst farmers and cattle vets if real progress is to be made.
David said: "There are some notable examples of veterinary practices that have worked with their clients to eliminate the use of CIAs. These are the exceptions, but they illustrate what is possible. As an industry, we need to speed up the rate of change and make a concerted effort to ensure more responsible use of antibiotics becomes the norm, sooner rather than later."
David quoted the British Cattle Veterinary Association (BCVA) position on the responsible use of medicines, which includes the recommendation of minimal use of third and fourth generation cephalosporins, fluoroquinalones and colistin, with these CIAs being limited to use where it has been demonstrated by sensitivity testing that they are the only suitable option to avoid unnecessary suffering.
"There has been agreement on this position amongst the veterinary associations, farmer organisations and milk buyers, but there needs to be more widespread awareness at producer level, particularly within the vet and farmer relationship.
"Farms with a robust herd health plan, where challenges are reduced, will be in the best position to minimise use of CIAs. This takes time and is most effective where there is good cooperation between the farm and its veterinary practice.
"Achieving a significant reduction in the use of CIAs voluntarily will not only minimise the likelihood of disruptive and potentially punitive legislation but will put our cattle industry on the front foot and strengthen its position in global markets."
It’s very simple.
If you’re a member of VetSurgeon.org, visit the site as soon as possible, and login.
You will then see a red box inviting you to subscribe to a NEW daily or weekly email digest of new questions posted by fellow vets. The box is on the main site home page, and on the community home page.
Subscribe. Today. Now. No time like the present.
Then, whenever you have a question, post it on the site and it will be added to the digest and sent to all subscribed members of the community.
When you get your VetSurgeon Digest, you’ll be presented with a list of the latest questions to skim, both clinical and non-clinical.
Some may catch your eye because you can help, others because you too are interested to know the answer.
Either way, time spent helping others with their questions, or reading answers, counts towards your annual CPD requirement for which you can generate a certificate on the site.
Furthermore, all questions and answers are databased as a searchable knowledge resource for everyone, so whether you’re asking or answering, you’re giving something back to your profession.
So, subscribe now! Did I say that already?
BENEFITS FOR VETERINARY SURGEONS
In short, this offers all the benefits of social media for knowledge-sharing, but with none of the baggage that so often comes with it.
The Practice Standards Group, which comprises representatives from all of the key veterinary and veterinary nursing organisations, has updated the standards of the Practice Standards Scheme and a draft of the new Manual is now available for comment.
The Scheme is a voluntary accreditation programme that aims to promote and maintain high standards of facilities and care within UK veterinary practices. When it was launched in 2005, a commitment was made that the standards would not change for five years, unless new legislation (such as the Veterinary Medicines Regulations) required it. Following a detailed review of the standards, to ensure they continue to be relevant to current veterinary practice, proposals have been made by the Group for new standards to be implemented during 2010.
Jill Nute, Chairman of the Practice Standards Group said: "It is unlikely that any already-accredited practices will be required to invest in additional facilities or equipment to meet the new standards.
"Instead, greater emphasis has been placed on clinical outcomes and training. For example, performance review has been introduced for all clinical staff, including the Professional Development Phase for new graduates. We are keen to hear feedback on the proposed new standards."
One recommendation is that the 'tiers' should be dropped. The categories will retain their descriptive names, for example, Small Animal General Practice or Equine Veterinary Hospital. Feedback suggests that clients, and the profession, found the tiers to be misleading.
The layout of the Manual has been revamped, to include guidance that was previously available online. Guidance for each relevant standard can now be seen at a glance. There is also an icon to indicate if documentary evidence will be required by the inspector. In addition, the new format clarifies the derivation of each standard, so that legislative requirements are distinguished from those required under the RCVS Guide to Professional Conduct and those indicated by better practice.
Membership of the Scheme continues to grow, with 126 applications to join the Scheme in the first six months of this year, representing 264 premises, compared with 61 applications in the whole of last year. There are currently 2,351 practice premises under the ambit of the Scheme - approximately 50%.
The draft new Manual is online at www.rcvs.org.uk/consultations.
Hard copies are available from Eleanor Ferguson, Practice Standards Scheme Manager: e.ferguson@rcvs.org.uk or 020 7202 0720.
The deadline for comments is 31 August 2009. Responses will be considered by the Practice Standards Group at its September meeting and thereafter by Council in November.
Ines, who graduated from the University of Santiago de Compostela in Spain in 2001, has spent the last seven years working at universities in America, Australia and Europe. She undertook her PhD in MR spectroscopy of the brain in dogs at the University of Bern-Zurich in Switzerland. She has a Masters in Radiology from University of Glasgow. She has also worked at the University of Illinois and Sydney University.
Willows clinical director Toby Gemmill said: "Ines is highly qualified and highly regarded, so is a very welcome addition to our talented imaging team. Her experience of working around the world will also be a terrific asset to the practice."
Ines said: "I am very happy and honoured to be joining Willows and to now be part of such a great diagnostic imaging team. "This is a well-known centre of excellence and I’m really looking forward to helping deliver the first class care and treatment that Willows always aims to provide."
For more information, visit www.willows.uk.net.
Adrienne Conroy, Head of BSAVA Policy and Chair of the Big Issues stream said: "As a profession, we have a history of successfully dealing with the unpredictable and rising to the challenge of the unexpected, which in many ways have been the hallmarks of the past year or so and no doubt will likely continue to be so for the foreseeable future.
"This year’s Big Issues stream will look at some of the uncertainties encountered by vets in practice and how resilience and resolve in the face of challenge can continue to serve the profession well for the future."
Big Issue subjects include:
The ABC of Achievements, Brexit and ChallengesProfessor the Lord Trees will aim to support vets’ understanding of the rationale underpinning the Government's Brexit decisions and their impact on the profession. A panel of speakers will also look at how the Government and the profession has worked collaboratively to introduce legislation and policies across a range of areas affecting the companion animal sector, and the practical implications for veterinary surgeons.
Medicines: Ensuring Supply Despite CrisesProfessor Peter Borriello, CEO of the Veterinary Medicines Directorate (VMD) and Dawn Howard CEO of the National Office of Animal Health (NOAH) will explore the unpredictable challenges, whether dependent on Brexit or other factors, that can potentially threaten the supply of medicines vital to companion animal veterinary practices and how these unexpected events can be tackled and resolved by working together.
The Perils of Passports and Certification: Avoiding LitigationBSAVA President Philip Lhermette, together with Dr Mauricio Lopez, Head of Veterinary Trade Facilitation, Animal and Plant Health Agency (APHA) and Michael Stanford, Veterinary Claims Consultant, Veterinary Defence Society (VDS) will share for the first time the results of the BSAVA 2018 OV survey, and will endeavour to better equip and support vets in companion animal practice to manage the unpredictable aspects of pet passports and export certification.
Telemedicine: Patient Care in the Digital WorldDr Kate Richards, Chair of the RCVS Standards Committee, Dr Thom Jenkins, CEO of Gula, Richard Guest, CEO of telemedicine consultancy Morgan Frey and Simon Doherty, President of the BVA aim to help delegates navigate relatively the unchartered territory of telemedicine and make informed decisions on the future of telemedicine and its potential impact on not just them, but also their clients.
More information on the Big Issues agenda and speakers here.
Ian Arundale (pictured right) was appointed as the new Chair of the DC following an application process from within existing Disciplinary Committee members, with the final interview panel consisting of Amanda Boag (President at the time), Ian Green (current DC Chair) and Miran Uddin (an independent barrister who works in regulatory law). Ian begins his role as chair in late October.
Ian is Deputy Chief Constable of Cleveland Police in the north east of England and was a police officer for 32 years serving in South Wales, West Mercia and Dyfed-Powys Police Forces. He currently provides expert witness services to inquests, courts and public inquiries. Ian has worked internationally and has assisted police forces and organisations in the USA, India, the Far East and New Zealand. In addition to his work with the RCVS, Ian is also the Chairperson of the Audit Committee for the City of Cardiff Council and is a board member of the International Law Enforcement Forum (ILEF).
Ian said: "I am pleased to have been selected as DC Chair and am looking forward to chairing the committee. The role of the DC is crucial to ensuring the RCVS protects and upholds the high standards of the UK veterinary professions, and I am humbled to be in a position to support this important function."
Dr Martin Whiting has been appointed as the new Vice Chair for the DC. Dr Whiting qualified as a veterinary surgeon from the Royal Veterinary College (RVC) in 2006. Following a few years in practice, he returned to academia to complete a Masters in Medical Law and Ethics and a PhD in the public interest in veterinary professional regulation. Martin was appointed as Lecturer in Veterinary Ethics and Law at the RVC in 2013 and became an RCVS and European Specialist in Animal Welfare, Ethics and Law. In 2017, Martin moved to the Home Office to work with the Animals in Science Committee and is currently the Head of Operations for the Animals in Science Regulation Unit.
Dr Bradley Viner has been appointed as the new Chair of the RCVS PIC and began his role on 1 July 2019.
Bradley was appointed through an independent selection process led by an external HR consultancy, with RCVS Council ratifying the final appointments. Bradley replaces Andrew Ash, who chaired the PIC from July 2015 up until Bradley’s appointment.
Bradley established his own small animal practice in Pinner, Middlesex, which then grew to a group of five practices in north-west London. In 2017 he sold his practices to the Linnaeus Group and now works for them as Group Clinical Quality Lead across all their sites. He was made a Fellow of the Royal College of Veterinary Surgeons in 2017 for Meritorious Contributions to Clinical Practice. Bradley was an elected member of RCVS Council between 2005 and 2017, including four years as RCVS Treasurer and one year as RCVS President in 2015-16.
Bradley said: "I was delighted to have been selected as Chair of this Statutory Committee as I feel it is one of the most important interfaces between the College, the profession and the public. It has a vital role to play in protecting animal welfare and the reputation of the profession, but I am well aware that fear of disciplinary proceedings can be very stressful to those involved. I undertake to continually strive to work to find a balance that ensures the Committee maintains a well-regulated profession acting in the public interest but also makes every effort to avoid causing unnecessary stress on members that are subject to its proceedings."
More information about the RCVS concerns investigation and disciplinary processes can be found at www.rcvs.org.uk/concerns.
Vouchers for twelve months' free access to Improve's Online Bitesize CPD series will be offered to veterinary surgeons, nurses and practice managers by their Protexin Territory Manager, based on their use of products in the Protexin range.
Online Bitesize CPD offers veterinary professionals the opportunity to meet their annual CPD requirements in short bursts of learning at a time and place to suit them. Its online modules of 20, 40 and 60 minutes cover a range of clinical topics, including cardiology, ophthalmology, small animal medicine, feline medicine and exotics.
Improve says the modules have been designed to be visually engaging, highly interactive and informative to ensure that the experience is rewarding.
James Kyffin, Veterinary Director at Protexin, said: "We are thrilled to be continuing our relationship with Improve International by offering practices access to its Online Bitesize CPD. We are passionate about education and Bitesize offers a convenient, exciting way for the profession to gain access to high quality CPD."
John Douglass at Improve International added: “We hope that veterinary professionals who have not yet experienced our training will take up the opportunity created by this association with Protexin Veterinary and learn new skills with our Online Bitesize CPD service for twelve months at no cost.
"The interactive modules we have created are led by recognised experts and will help them to refresh their knowledge, learn new skills and achieve their annual CPD points quota online at any time.”
The company says a combination of unprecedented demand for the product and logistics issues, together with an issue involving the manufacturer of the active ingredient, has resulted in a delay in receiving stock into the UK.
Animalcare says it has a shipment awaiting dispatch to the UK from its European manufacturing plant as soon as licensing is completed by the VMD, Home Office and European counterparts. There is another batch in production, expected into the UK in early March.
Kai Crawshaw, Product Manager at Animalcare, said: "We are working hard with the VMD and Home Office to expedite the import licensing process and also with our manufacturer to ensure we can get as much stock as quickly as possible back into the marketplace. We sincerely apologise to any clinics that are experiencing a shortage but are glad to say that stock is on the way."
The company has completed a health hazard assessment which concluded that any risk to animal and human health is likely to be low and no greater than expected for this product under normal conditions, as described on the product labelling.
The recall is for the following batches only:
Batch Numbers:
0265-900302-900246-900112-900295-909053-919103-91
Norbrook Laboratories Ltd is contacting veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.
For further information, contact Gary Mckee on +44 2830 264435 or email gary.mckee@norbrook.co.uk
The MSD Animal Health Vet Surgeon Research Bursary offers awards of up to £4,000 each. Each project has to be completed within one to two years and the veterinary surgeon proposals are judged by university academics to ensure independent assessment.
Michelle Townley, veterinary advisor at MSD Animal Health said: "We’re delighted to be awarding Amie this bursary as we consider deepening the understanding of equine vaccination practices and protocols to be important new knowledge for the companion animal sector, especially in the light of the recent equine flu outbreak.
"We will be inviting applications for the 2019 vet surgeon bursaries from August this year so would encourage any vet keen to develop their research skills to keep an eye on our website for further information. We would like to encourage as many vets as possible to apply as part of our commitment to advancing research within the veterinary industry."
2018 is the second year MSD Animal Health has extended its Veterinary Surgeon Research Bursary to include companion animals. The 2017 award went to Dr Sarah Caddy for her research into cat bite abscesses.
Veterinary surgeon research bursary applications will open again in August.
For more information, visit www.msdahresearchbursary.co.uk.
The Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons has suspended a veterinary surgeon for a period of six months for issuing two false horse passports, having found him to have been “consciously dishonest”.
At a hearing which concluded on 15 July, Andrew Dominic Illing, Director of the Chapelfield Veterinary Partnership, Norwich, admitted charges of backdating the passports of two different horses on 1 May 2008, to indicate that they had been vaccinated on 24 April 2008 against equine influenza and equine influenza and tetanus, when he knew that the vaccinations had not been carried out on that date.
The Committee heard that, whilst on a routine visit to a local livery yard on 30 April 2008, a junior veterinary surgeon at the practice, Ms Charlotte Alice Mayers, had been pressured to backdate the equine passports of two horses, owned by Mrs Scriven and Mrs Kippen respectively, because their booster vaccinations had been carried out beyond the 12-month window prescribed by the Horse Racing Authority. Ms Mayers had declined to do so and had brought the passports back to the practice to seek the advice of its Director, Mr Illing.
Ms Mayers explained to Mr Illing, both in a note and in discussion with him, that the boosters had been administered outwith the prescribed period and that she had told the owners that she was not willing to backdate the passports, one of which she had already signed. The DC heard that Mr Illing had told Ms Mayers “not to worry about it” and that he would deal with the situation. It did not surface until the livery yard manager later made a complaint, that Mr Illing had in fact signed the second passport and backdated both to 24 April.
In mitigation, Mr Illing said that he had been under considerable stress at the time, as he had been dealing with a protracted and difficult disciplinary meeting concerning a senior veterinary colleague. As a consequence of this, the Committee heard from Mr Illing’s practice partner that Mr Illing was required to take on more work than he was already performing, which was already 10-15% more than the other three vets in the practice. In addition, Mr Illing had been in a degree of pain at the time, following a knee injury. The Committee also heard evidence from a veterinary surgeon who testified to Mr Illing’s good character; and received many written testimonials.
In reaching its decision, the Committee held the view that: “the public must be able to trust certificates which are signed by members of this profession. If the public cannot trust the authenticity of such certificates, the Committee considers that public confidence in the profession would be undermined, and undermined in a very significant way.” It also cited the obligations of the RCVS Guide to Professional Conduct in terms of the integrity of veterinary certification, and the ‘12 Principles of Certification’, as agreed by the RCVS, the British Veterinary Association and the Department of Environment, Food and Rural Affairs.
The Committee considered many factors when making its final decision. It did not accept that stress overbore Mr Illing’s normal way of dealing with certification, particularly where he had had a period of overnight reflection before taking the action that he did. However, it felt that the most troubling feature in his decision to backdate the certificates was that, in advising Ms Mayers on a difficult ethical issue, Mr Illing had “set a disgraceful example and wholly failed to provide her with the support to which she was entitled”. Furthermore, in backdating a certificate that Ms Mayers had already signed, he was putting her integrity at risk.
Alison Bruce, chairing the Committee, commented: “It is only by upholding the importance of each and every certificate issued by a member of the veterinary profession that public confidence in such certificates can be maintained.” She went on to say: “Without significant mitigating circumstances, false certification will result in removal from the Register. In Mr Illing’s case, having regard to all the evidence, both the oral and written testimonials, and taking into account all the aggravating and mitigating circumstances detailed above, the Committee has decided to suspend Mr Illing’s name from the Register for a period of six months.”
Probably the two most popular social media platforms for veterinary surgeons in the UK are Facebook (and its various veterinary groups) and VetSurgeon.org.
Facebook has the advantage that so many people use it to share photographs with family and friends, so they are already on the site and it is only a very short hop over to participate in a veterinary discussion group. That makes it an excellent way to get a broad opinion on almost any subject.
But, and it is a very big 'but', Facebook was never designed to be a platform for sharing clinical information or discussing cases. So, for example, you cannot see the professional qualifications of anyone contributing to the discussion unless they happen also to be your 'friend', so it can be hard to tell whether they have any idea what they're talking about, or are, in fact, the leading light.
There are various other aspects of Facebook that are problematic when it comes to clinical discussions, including the difficulty in referring back to useful information shared and the way in which 'me too' replies can drown out good quality information.
The survey aims to find out how much of a problem vets think these things are, whether certain groups within the profession could be better served by social media - for example those that may find it daunting asking for help in an online group, and what features vets would like VetSurgeon.org to invest in.
The survey can be completed anonymously, but if you give your name at the end, you'll be entered into a draw for a case of champagne (or equivalent).
Take part here: https://bit.ly/2lzzpy4
Please share this story amongst your colleagues!
Nutraplaque contains Ascophyllum Nodosum seaweed and decaffeinated green tea extract, presented in sprinkle capsules. Nutravet says the seaweed in nutraplaque has been shown to reduce plaque build-up by 35% after 4 weeks.
Nutravet says the new product also helps in the removal and control of tartar, supports healthy teeth and gums, reduces bad breath and is free of artificial preservatives, gluten and sugar
Matthew Shaw, Managing Director at Nutravet said: "We’re really excited to introduce nutraplaque into our market-leading range of veterinary exclusive nutraceuticals. Maintaining pets’ dental health is an important part of looking after a pet and our nutraplaque sprinkle capsules make it easy for pet owners to keep up with oral health in an easy to administer form.
“The unique formulation of nutraplaque works naturally within an animal’s body. The natural ingredients work through the saliva, where they help reduce new plaque from forming and soften existing tartar around the clock."
For further information about nutraplaque, visit www.nutravet.co.uk.
Norbrook Laboratories has announced the addition of new indications to its Loxicom (meloxicam) products, two regarding its use in cats, and the other in calves.
Loxicom 5mg/ml solution for injection for dogs and cats is now indicated for the management of post-operative pain in cats. An injection given around the time of surgery can be followed up with a course of Loxicom 0.5 mg/ml oral suspension for cats. Alternatively, for cats where no follow-up oral treatment is possible, for example with feral cats, a larger dose of the injectable formulation can be given at the time of surgery.
Norbrook's EU Veterinary Advisor, Rebekah Dudek MRCVS, said: "Norbrook is pleased to be able to now offer vets two on-licence choices in relation to how they want to use their 5mg/ml meloxicam injection in cats. This gives vets the flexibility they need to be able to deal effectively with the wide variety of cases they see every day."
Loxicom 20mg/ml solution for injection for cattle, pigs and horses has now been licenced for the relief of post-operative pain following dehorning in calves.
Norbrook says that the use of a non-steroidal antiinflammatory drug (NSAID) alongside local anaesthetic has clear benefits for animal welfare, and that use at this time is also shown to offer economic benefits to the farmer, with increased food-conversion efficiency compared to untreated calves1.
Rebekah said: "Dehorning in calves has long been known as a painful procedure, with a negative impact on feed intake in the post-operative period. With our latest licence, Loxicom 20mg/ml can now be used for relief of this potentially economically important post-operative pain in calves."
Reference
Entitled ‘Managing mitral valve disease from start to finish’, the course will account for four hours’ CPD split into six short bite-size sessions which can be completed at your own pace.
The sessions are presented by Dr Mike Martin MVB DVC MRCVS, and business thought leader, Dr Alison Lambert BVSc CMRS MRCVS. They consist of a practical review of MVD both pre-clinically and clinically and how to diagnose and stage it following the new 2019 American College of Veterinary Internal Medicine (ACVIM) Consensus guidelines.
The course also includes tips on how to treat and manage dogs with MVD with diuretic management; a step-by-step guide to treatment options for acute and long-term management of congestive heart failure and how to troubleshoot problem congestive heart failure cases.
There's also a bonus ‘Communicating Cardiology’ session which looks at how to communicate the heart disease journey to owners.
To register for the course visit www.veterinarywebinars.com/mvd-reg.
Ceva will donate £2 for every veterinary professional completing the course throughout February and March 2021 to Vetlife, which provides support to the veterinary community and their families who have emotional, health or financial concerns.
Jane, who has also just been appointed to chair IVC's Small Animal Clinical Board, was awarded the certification in recognition of her dedication to professional development, having achieved 180 post graduate points for the Masters level award.
Jane already holds a PG certificate in Emergency Medicine and Surgery, a postgraduate diploma in Advanced Veterinary Practice Sciences, GP certificates in Small Animal Surgery and Advanced Small Animal Orthopaedic Surgery and a Focus Certificate in Veterinary Arthroscopy.
She is also an RCVS advanced practitioner in small animal surgery and in emergency medicine and critical care and is currently studying for further certifications in pain management and small animal musculoskeletal ultrasound.
Jane said: "I have always loved learning, and CPD has been incredibly important throughout my career to date.
"I’ve worked hard over the last 35 years to gain additional qualifications and to take advantage of every development opportunity I could to build on my own knowledge and capabilities.
“I very much look forward to sharing this experience and working with the rest of the board to support our small animal colleagues across IVC Evidensia in providing the best possible standards of care.”
The anti-emetic, Cerenia (maropitant citrate), has gained licenses for use in puppies from as young as eight weeks of age and in cats from 16 weeks of age in the prevention and treatment of vomiting and reduction of nausea.
Cerenia is an NK-1 receptor antagonist which Pfizer says is effective against both peripheral and central emetic stimuli by acting on the final common pathway for emesis. It is, according to the company, the only NK-1 receptor antagonist licensed for dogs and cats.
Pfizer adds that in addition to the use for general emesis in puppies, Cerenia can also be used for chemotherapy-induced nausea in dogs. Studies in human oncology show that some patients receiving chemotherapy consider nausea to be more distressing than vomiting1. and the use of NK-1 receptor antagonists has shown clear benefits in the prevention of nausea and vomiting in chemotherapy-treated humans2. Cerenia tablets are also for the treatment for motion sickness in dogs aged 16 weeks or older, delivering claimed efficacy up to 93% without sedating the dog.
Kate Grocott, Product Manager for Cerenia, said: "Already successfully used in the treatment and prevention of vomiting and chemotherapy nausea in dogs, the new licence is a positive step forward for the prevention and early treatment of vomiting for puppies as young as eight weeks of age and cats from 16 weeks old. Being able to deploy Cerenia in these cases, will improve quality of life, and increases the likelihood of the animal voluntarily taking food and water thereby assisting in the recovery where there is underlying disease."
The new licence for treatment of cats with Cerenia is associated with the injectable form, while puppies may be treated with either an injection or tablets.
For further information, contact your Pfizer Animal Health account manager or call 0845 300 8034.
References
From now on, accredited General Practices will need to employ at least one Registered Veterinary Nurse (RVN), whilst at Veterinary Hospitals all patients should now have a nursing plan in place, and an RVN will need to be on duty at all times.
Other changes to the PSS requirements include:
The full list of changes to the Practice Standards Scheme, together with the new module and award documents, can be found at: www.rcvs.org.uk/PSSreview.
David Ashcroft leads the team of PSS Assessors responsible for undertaking practice visits and assessing if they meet the required standards. He said: “The changes will come into force later in the year, at the same time as we are planning to return to in-person assessments, and so timings will be subject to government guidance on coronavirus and the easing of lockdown restrictions.
“As the PSS returns to in-person assessments, practices will have the usual three-month period between booking the assessment and the assessment taking place with which to familiarise themselves with the changes and the modules documents relevant to their accreditation.
“If anyone has any questions about the changes then please make sure to contact the Practice Standards Team on pss@rcvs.org.uk and we will be happy to help in any way we can.”
An impurity was detected during stability monitoring. The impurity was isolated and the best estimate of identity indicated that the impurity is carprofen related.
The problem affects a limited number of batches and is identifiable through quality control testing. The concentration of the process impurity does not increase over time.
This recall is for the following batches only:
Norbrook is contacting wholesale dealers and veterinary surgeons to examine inventory and quarantine products subject to this recall.
For further information regarding the recall, contact Gary Mckee on 0044 2830 264435 or by email: gary.mckee@norbrook.co.uk
MSD Animal Health has launched Zuprevo Cattle, which contains a novel antibiotic molecule to help combat bovine respiratory disease (BRD).
Zuprevo Cattle contains the active ingredient tildipirosin (180mg/ml), a new 16-membered, tribasic macrolide unique to animal health. It is licensed for the treatment and prevention of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni.
According to MSD Animal Health livestock veterinary adviser Paul Williams MRCVS, the new product works extremely quickly in the animal, as well as offering the longest duration of activity in the lungs of all the macrolide antibiotics currently on the market. He says it is also extremely convenient to use: "Zuprevo is readily absorbed by the animal, reaching peak plasma concentrations within 23 minutes of injection. Zuprevo is readily distributed around the body and reaches lung concentration well above MIC90 for all of the three BRD target pathogens within four hours of administration. In addition, it maintains lung concentration above the MIC90 for up to 28 days, which will appeal to many practitioners."
Paul says that it is Zuprevo's 16-membered, tribasic macrolide structure that allows it to deliver these significant pharmacological benefits for the management of BRD in cattle: "Zuprevo works by diffusing into the bacterial cell where its binding action inhibits protein synthesis of the bacterial ribosome. Its unique 16-membered, tribasic structure enables enhanced penetration of the bacterial cell wall, as well as having the ability to bypass some potential bacterial resistance mechanisms."
Paul says Zuprevo also offers vets and their farmer clients important practical usage advantages: "Zuprevo is an easily syringeable solution for injection available in convenient 20ml, 50ml and 100ml vial sizes to suit different usage requirements. At a dose rate of 1ml/45kg, it offers the lowest macrolide dose volume per kg of bodyweight. At 47 days, Zuprevo also has the shortest macrolide meat withdrawal period."
Further information on this new macrolide antibiotic is available from the MSD Animal Health territory managers or by calling the company's Veterinary Services Group on 01908 685685.